Trials / Recruiting
RecruitingNCT06934473
Effects of Endogenous GIP on Postprandial Blood Pressure in Healthy Individuals
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (estimated)
- Sponsor
- University Hospital, Gentofte, Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The present study investigates the postprandial role of endogenous glucose-dependent insulinotropic polypeptide (GIP) on cardiovascular haemodynamics, hormone responses, and hypotensive symptoms during a tilt test.
Detailed description
The study is an exploratory, randomised, placebo-controlled, double-blinded crossover study comprising four experimental days. Each experimental day consists of a mixed meal test or drinking water, a double-blinded continuous infusion of GIP(3-30)NH2 or placebo or GIP(1-42) or placebo, and three tilt tests. Sixteen healthy men and women will be included in the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | GIP(3-30)NH2 / study tool | Selective antagonist of the GIPR, GIP(3-30)NH2 |
| OTHER | Saline (NaCl 0,9 %) (placebo) | Placebo (NaCl 0,9%) |
| OTHER | GIP(1-42) | Agonist of the GIPR, GIP(1-42) |
Timeline
- Start date
- 2025-05-21
- Primary completion
- 2026-01-31
- Completion
- 2026-01-31
- First posted
- 2025-04-18
- Last updated
- 2025-09-08
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT06934473. Inclusion in this directory is not an endorsement.